|
Market Closed -
Euronext Paris
19:55:00 28/10/2026 +03
|
After hours 23:50:58 | |||
| 1.278 EUR | +0.47% |
|
1.303 | +1.96% |
| 10-27 | AstraZeneca Delays Data Readout for Phase 3 Trial of Lung Cancer Combination Treatment | MT |
| 10-27 | Timeline Delayed for Innate Pharma and AstraZeneca Trial |
Chart: Technical Analysis
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| IPH | Real-time | |
CBOE
| IPHp | Real-time | |
Börse Stuttgart
| IDD | Delayed | |
Tradegate
| IDD | Real-time | |
OTC Markets
| IPHYF | Delayed | |
Deutsche Boerse AG
| IDD | Delayed | |
Xetra
| IDD | Delayed | |
London S.E.
| 0EVI | Delayed | |
CBOE
| 0EVI | Real-time | |
Boerse Muenchen
| IDD | Real-time | |
Borsa Italiana
| 4IPH | End-of-day quote | |
Nasdaq
| INNTY | Delayed | |
CBOE
| INNTY | Real-time | |
Deutsche Boerse AG
| IDDA | Delayed | |
Boerse Muenchen
| IDDA | Real-time | |
Börse Stuttgart
| IDDA | Delayed |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 1.402 | 2.19 | 1.908 |
| Spread/Res. | -8.84% | -41.64% | -33.02% |
| Spread/Supp. | +4.07% | +4.07% | +18.99% |
| Support | 1.228 | 1.228 | 1.074 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- IPH Stock
- Charts Innate Pharma
Select your edition
All financial news and data tailored to specific country editions

















